Special Issue "Pathogenesis, Characterization and Vaccine Development of Viral Nervous Necrosis"
Deadline for manuscript submissions: 30 June 2021.
Interests: diagnosis and control of fish viruses, with special reference to viral nervous necrosis
Interests: pathogenesis of fish diseases, with special reference to viral nervous necrosis; in vivo fish experiments
Interests: fish viruses; IPNV; NNV; diagnostics; virulence; epidemiology
Special Issues and Collections in MDPI journals
Viral nervous necrosis (VNN), also known as viral encephalo-retinopathy (VER), is a severe neurological disease caused by small RNA viruses belonging to the genus Betanodavirus. The extreme environmental resistance, the increasing host range and the global warming, which will probably contribute to increasing the number/severity of the outbreaks, make the threat posed by this agent to global aquaculture extremely significant. Although the body of knowledge related to VNN has increased considerably in recent years, there are several aspects of the pathogenesis and of the immunological response to natural and experimental infection that need to be further investigated. Additionally, the development of safe and efficacious vaccines is only at the very early stages, and needs to be quickly implemented. Ideally, vaccines should target larvae and broodstock stages and should be cross-protective or applicable to different fish species, in order to help the industry deal with the problem of vertical transmission and farmed–wild fish interaction.
Such knowledge will be instrumental to develop effective VNN control methods and to reduce the impact of this disease on worldwide aquaculture. For these reasons, researchers actively engaged in studies on the characterization of Betanodaviruses by molecular biology, biochemistry, and/or virology; in vivo experiments to unravel disease pathogenesis; as well as vaccine development and testing are enthusiastically encouraged to submit their works to this Special Issue.Dr. Anna Toffan
Dr. Francesco Pascoli
Prof. Isabel Bandín
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pathogens is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1500 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- viral nervous necrosis
- viral encephalo-retinopathy